✦ LIBER ✦

Letter: thiopurine blood monitoring for patients with inflammatory bowel disease – authors' reply

✍ Scribed by L. Chouchana; C. Narjoz; P. Beaune; M.-A. Loriot; X. Roblin

Book ID: 108606615
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 52 KB
Volume: 35
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2012.05003.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Letter: thiopurine blood monitoring for

Letter: thiopurine blood monitoring for patients with inflammatory bowel disease

✍ W. El-Matary 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Clinical usefulness of therapeutic drug

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

✍ Melissa L. Haines; Yousef Ajlouni; Peter M. Irving; Miles P. Sparrow; Rosemary R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Background: Circulating concentrations of 6-thioguanine nucleotide (6-TGN) and 6-methyl mercaptopurine (6-MMP) are associated with thiopurine efficacy and may predict toxicity. This study aimed to examine retrospectively the utility of measuring metabolite concentrations in patients with inflammator

The multidrug-resistance protein 4 polym

The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease

✍ Hiromistu Ban; Akira Andoh; Hirotsugu Imaeda; Ayako Kobori; Shigeki Bamba; Tomoy 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 273 KB